The Federal Judiciary struck down a DC Law enacted this year designed to help limit the cost of prescription drugs to a percentage above foreign wholesale costs. This, of course, is against that whole federal patent law thing, not to mention the very important interstate commerce clause of that pesky US Constitution. There’s more detail and analysis over at Just Barely Inside the Beltway.
This post appeared in its original form at DC Metblogs